aTyr Pharma, Inc. (FRA:471A)
Germany
· Delayed Price · Currency is EUR 0.560
+0.050 (9.80%)
At close: Dec 4, 2025
aTyr Pharma Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | 0.19 | 0.24 | 0.35 | 10.39 | - | 10.46 | Upgrade
|
| Revenue Growth (YoY) | -19.15% | -33.43% | -96.60% | - | - | 2377.49% | Upgrade
|
| Cost of Revenue | 61.56 | 54.37 | 42.29 | 42.81 | 23.26 | 17.29 | Upgrade
|
| Gross Profit | -61.37 | -54.14 | -41.94 | -32.42 | -23.26 | -6.84 | Upgrade
|
| Selling, General & Admin | 17.29 | 13.78 | 12.98 | 13.98 | 10.75 | 9.08 | Upgrade
|
| Operating Expenses | 17.29 | 13.78 | 12.98 | 13.98 | 10.75 | 9.08 | Upgrade
|
| Operating Income | -78.65 | -67.91 | -54.92 | -46.4 | -34.02 | -15.91 | Upgrade
|
| Other Non Operating Income (Expenses) | 3.52 | 3.89 | 4.52 | 1.06 | 0.24 | -0.32 | Upgrade
|
| EBT Excluding Unusual Items | -75.13 | -64.02 | -50.4 | -45.34 | -33.78 | -16.23 | Upgrade
|
| Pretax Income | -75.13 | -64.02 | -50.4 | -45.34 | -33.78 | -16.23 | Upgrade
|
| Earnings From Continuing Operations | -75.13 | -64.02 | -50.4 | -45.34 | -33.78 | -16.23 | Upgrade
|
| Minority Interest in Earnings | 0.01 | -0 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Net Income | -75.12 | -64.02 | -50.39 | -45.34 | -33.77 | -16.22 | Upgrade
|
| Net Income to Common | -75.12 | -64.02 | -50.39 | -45.34 | -33.77 | -16.22 | Upgrade
|
| Shares Outstanding (Basic) | 89 | 74 | 54 | 28 | 19 | 9 | Upgrade
|
| Shares Outstanding (Diluted) | 89 | 74 | 54 | 28 | 19 | 9 | Upgrade
|
| Shares Change (YoY) | 30.37% | 38.53% | 88.63% | 48.94% | 108.30% | 172.99% | Upgrade
|
| EPS (Basic) | -0.84 | -0.86 | -0.94 | -1.60 | -1.77 | -1.77 | Upgrade
|
| EPS (Diluted) | -0.84 | -0.86 | -0.94 | -1.60 | -1.77 | -1.77 | Upgrade
|
| Free Cash Flow | -62.99 | -69.18 | -37.44 | -43.53 | -33.27 | -15.5 | Upgrade
|
| Free Cash Flow Per Share | -0.71 | -0.93 | -0.70 | -1.53 | -1.74 | -1.69 | Upgrade
|
| Gross Margin | - | - | - | - | - | -65.39% | Upgrade
|
| Operating Margin | -41395.26% | -28899.57% | -15557.79% | -446.79% | - | -152.19% | Upgrade
|
| Profit Margin | -39537.89% | -27243.83% | -14274.50% | -436.53% | - | -155.18% | Upgrade
|
| Free Cash Flow Margin | -33154.21% | -29440.00% | -10605.10% | -419.09% | - | -148.28% | Upgrade
|
| EBITDA | -77.98 | -67.21 | -54.33 | -46.17 | -33.54 | -15.34 | Upgrade
|
| EBITDA Margin | - | - | - | - | - | -146.74% | Upgrade
|
| D&A For EBITDA | 0.67 | 0.71 | 0.59 | 0.23 | 0.48 | 0.57 | Upgrade
|
| EBIT | -78.65 | -67.91 | -54.92 | -46.4 | -34.02 | -15.91 | Upgrade
|
| EBIT Margin | - | - | - | - | - | -152.19% | Upgrade
|
| Revenue as Reported | 0.19 | 0.24 | 0.35 | 10.39 | - | 10.46 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.